Abstract
The scarcity of organs and tissues for transplant and the need of immunosuppressive drugs to avoid rejection constitute two reasons that justify organ and tissue production in the laboratory. Tissue engineering based tissues (TE) could allow to regenerate the whole organ from a fragment or even to produce several organs from an organ donor for grafting purposes. TE is based in: (1) the ex vivo expansion of cells, (2) the seeding of these expanded cells in tridimensional structures that mimic physiological conditions and, (3) grafting the prototype. In order to graft big structures it is necessary that the organ or tissue produced “ex vivo” bears a vascular tree to ensure the nutrition of its deep layers. At present, no technology has been developed to provide this vascular tree to TE derived products. Thus, these tissues must be thin enough to acquire nutrients during the first days by diffusion from surrounding tissues. This fact constitutes nowadays the greatest limitation of technologies for organ development in the laboratory.
In this chapter, all these problems and their possible solutions are commented. Also, the present status of TE techniques in the regeneration of different organ systems is reviewed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Moreno-Borchart A. Building organs piece by piece. EMBO rep 2004; 5:1025–1028.
Falke G, Atala A. Reconstrucción de tejidos y órganos utilizando ingeniería tisular. Arch Argent Pediatr 2000; 98:103–115.
O’ Connor NE, Mulliken JB, Banks-Schlegal S et al. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1981; 1:75–78.
Vacanti C. The history of tissue engineering. J Cell Mol Med 2006; 10:569–576.
Brittberg M, Lindahl A, Nilsson A et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994; 331:889–895.
Perin L, Giuliani S, Sedrakyan S et al. Stem cell and regenerative science applications in the development of bioengineering of renal tissue. Pediatr Res 2008; 63:467–471.
Choumerianou D, Dimitriou H, Kalmanti M. Stem cells: promises versus limitations. Tissue Eng Part B Rev 2008; 14:53–60.
Da Silva Meirelles L, Caplan A, Beyer N. In search of the in vivo identity of mesenchymal. Stem Cells 2008; 26:2287–2299.
Toda A, Okabe M, Yoshida T et al. The potential of amniotic membrane/amnion-derived cells for the regeneration of various tissues. J Pharmacol Sci 2007; 105:215–228.
De Coppi P, Bartsch G Jr, Siddiqui MM et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25:100–106.
Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:1–12.
Raya A, Rodriguez-Piza I, Navarro S et al. A protocol describing the genetic correction of somatic human cells and subsequent genration of iPSC cells. Nat Protoc 2010; 5:647–660.
Patterson TE, Kumagai K, Griffith L et al. Cellular strategies for enhancement of fracture repair. J Bone Joint Surg Am 2008; 90 Suppl 1:111–119.
Lee J, Cuddihy M, Kotov N. Three-dimensional cell culture matrices: State of the art. Tissue Eng Part B Rev 2008; 14:61–86.
Mironov V, Boland T, Trusk T et al. Organ printing: computer-aided jet-based 3D tissue engineering. Trends in Biotechnology 2003; 21:157–161.
Ott HC, Matthiesen TS, Goh SK et al. Perfussion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat Med 2008; 14:213–221.
Grayson WL, Chao PH, Marolt D et al. Engineering custom-designed osteochondral tissue grafts. Trends Biotechnol 2008; 26:181–189.
Bilodeau K, Mantovani D. Bioreactors for tissue engineering: Focus on mechanical constraints. A comparative review. Tissue Engineering 2006; 12:2367–2383.
Freed L, Guilak F, Guo E et al. Advanced tools for tissue engineering: scaffolds, biorreactors and signaling. Tissue Engineering 2006; 12:3285–3305.
Taylor DA. From stem cells and cadaveric matrix to engineered organs. Current Opinion in Biotechnology 2009; 20:598–605.
Segers V, Lee RT. Stem cell therapy for cardiac disease. Nature 2008; 451:937–942.
Mendelson K, Schoen FJ. Heart valve tissue engineering: concepts, approaches, progress and challenges. Ann Biomed Eng 2006; 34:1799–1819.
Vesely I. Heart valve tissue engineering. Circ Res 2005; 97:743–755.
L’Heureux N, Dusserre N, Marina A et al. Technology insight: the evolution of tissue-engineered vascular grafts-from research to clinical practice. Nat Clin Pract Cardiovasc Med 2007; 4:389–395.
Meinhart JG, Deutsch M, Fischlein T et al. Clinical autologous in vitro endothelialization of 153 infrainguinalePTFE grafts. Ann Thorac Surg 2001; 71:S327–S331.
Shin’oka T, Matsumura G, Hibino N et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005; 129:1330–1338.
L’Heureux N, Dussrre N, Koning G et al. Human tissue engineered blood vessel for adult arterial revascularization. Nat Med 2006; 12:361–365.
Guillemette M, Gauvin R, Perron C et al. Tissue-Engineered vascular adventitia with vasa vasorum improves graft integration and vascularization through inosculation. Tissue Eng Part A 2010; 16:2617–2626.
Petersen T, Calle E, Zhao L et al. Tissue-engineered lungs for in vivo implantation. B. Science 2010; 329:538–541.
Macchiarini P, Jungebluth P, Go T et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008; 372:2023–2030.
Fieguel H, Kaufmann P, Bruns H et al. Hepatic tissue engineering: from transplantation to customized cell-based directed therapies from the laboratory. J Cell Mol Med 2008; 12:56–66.
Stadlbauer V, Jalan R. Acute liver failure: liver support therapies. Curr Opin Crit Care 2007; 13:215–221.
Naruse K, Tang W, Makuuchi M. Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients. World J Gastroenterol 2007; 13:1516–1521.
Uygun BE, Soto-Gutierrez A, Izamis ML et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nature Medicine 2010; 16:814–820.
Atala A. Bioengineered tissues for urogenital repair in children. Pediatr Res 2008; 63:569–575.
Fissell WH, Manley S, Westover A et al. Differentiated growth of human renal tubule cells on thin-film and nanostructured materials. ASAIO J 2006; 52:221–227.
Romagnoli G, De Luca M, Faranda F et al. Treatment of posterior hypospadias by the autologous graft of cultured urethral epithelium. N Engl J Med 1990; 323:527–530.
Atala A, Bauer SB, Soker S et al. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006; 367:1241–1246.
Kneser U, Schaefer DJ, Polykandriotis E et al. Tissue engineering of bone: the reconstructive surgeon’s point of view. J Cell Mol Med 2006; 10:7–19.
Clar C, Cummins E, McIntyre L et al. Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation. Health Technol Assess 2005; 9 nº 47.
Petrigliano F, McAllister D, Wu B. Tissue engineering for anterior cruciate ligament reconstruction: a review of current strategies. Arthroscopy 2006; 22:441–451.
Atiyeh BS, Costagliola M. Cultured epithelial autograft (CEA) in burn treatment: three decades later. Burns 2007; 33:405–413.
Llames S, Del Rio M, Larcher F et al. Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin. Transplantation 2004; 7:350–355.
Rama P, Matiska S, Paganoni G et al. Limbal stem-cell therapy and long-term corneal regeneration. N Engl J Med 2010; 363:147–155.
Chalfoun CT, Wirth GA, Evans GR. Tissue engineered nerve construct: Where do we stand? J Cell Mol Med 2006; 10:309–317.
Willerth S, Sakiyama-Elbert S. Approaches to neural tissue engineering using scaffolds for drug delivery. Adv Drug Deliv Rev 2007; 59:325–338.
Cramer SC. Repairing human brain after stroke. II Restorative Therapies. Ann Neurol 2008; E63:549–560.
Thuret S, Moon L, Gage FH. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci 2006; 7:628–643.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Llames, S., García, E., Otero Hernández, J., Meana, Á. (2012). Tissue Bioengineering and Artificial Organs. In: López-Larrea, C., López-Vázquez, A., Suárez-Álvarez, B. (eds) Stem Cell Transplantation. Advances in Experimental Medicine and Biology, vol 741. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2098-9_20
Download citation
DOI: https://doi.org/10.1007/978-1-4614-2098-9_20
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-2097-2
Online ISBN: 978-1-4614-2098-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)